Financhill
Sell
13

TERN Quote, Financials, Valuation and Earnings

Last price:
$2.09
Seasonality move :
-20.89%
Day range:
$1.94 - $2.43
52-week range:
$1.87 - $11.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.58x
Volume:
2.2M
Avg. volume:
1.2M
1-year change:
-58.48%
Market cap:
$200.8M
Revenue:
--
EPS (TTM):
-$1.13

Earnings Data

Next earnings date for TERN
May 13
2025
Most recent earnings per share
-$0.24
Beat by $0.06
(Mar 20/2025)
Consensus Estimate
-$0.30
(Mar 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TERN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.29 --
05/13/2025 Q1 -- -- -- -$0.27 --
03/20/2025 Q4 -- -- -$0.24 -$0.30 $0.06
11/12/2024 Q3 -- -- -$0.28 -$0.32 $0.04
08/05/2024 Q2 -- -- -$0.31 -$0.34 $0.03
05/13/2024 Q1 -- -- -$0.30 -$0.35 $0.05
03/14/2024 Q4 -- -- -$0.29 -$0.29 $0.00
11/14/2023 Q3 -- -- -$0.42 -$0.31 -$0.11
08/08/2023 Q2 -- -- -$0.25 -$0.33 $0.08
05/15/2023 Q1 -- -- -$0.31 -$0.27 -$0.04
03/27/2023 Q4 -- -- -$0.29 -$0.44 $0.15
11/09/2022 Q3 -- -- -$0.44 -- --
08/08/2022 Q2 -- -- -$0.55 -- --
05/16/2022 Q1 -- -- -$0.55 -- --
03/03/2022 Q4 -- $1M -$0.56 -- --
11/15/2021 Q3 -- -- -$0.47 -- --
08/16/2021 Q2 -- -- -$0.43 -- --
05/14/2021 Q1 -- -- -$0.88 -- --
12/31/2020 Q4 -- -- $0.03 -- --
09/30/2020 Q3 -- -- -$0.48 -- --
06/30/2020 Q2 -- -- -$0.40 -- --
03/31/2020 Q1 -- -- -$0.38 -- --
12/31/2019 Q4 -- -- -$0.41 -- --

Terns Pharmaceuticals Earnings Questions

  • How Much did Terns Pharmaceuticals Generate in Revenue Last Quarter?

    Terns Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Terns Pharmaceuticals Beat Earnings Last Quarter?

    Terns Pharmaceuticals announced earnings per share of -$0.24 which represents a beat of analyst forecast a -$0.30 per share.

  • Is Terns Pharmaceuticals Profitable?

    Terns Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Terns Pharmaceuticals EPS Next Year?

    Terns Pharmaceuticals's earnings are forecast to decrease from -$1.12 per share to -$1.20 per share next year representing a decrease of -6.8%.

  • When is Terns Pharmaceuticals's Earnings Date?

    Terns Pharmaceuticals's next earnings date is May 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.

Sell
31
TECS alert for Apr 10

Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.

Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock